CWM
EW icon

Compass Wealth Management’s Edwards Lifesciences EW Stock Holding History

Compass Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-264
Closed -$24.4K – 400
2024
Q2 		$24.4K Buy
+264
New +$23.4K 0.01% 312
2023
Q4 		– Sell
-264
Closed -$18.3K – 391
2023
Q3 		$18.3K Buy
+264
New +$21.2K 0.01% 321
2023
Q2 		– Sell
-414
Closed -$34.3K – 417
2023
Q1 		$34.3K Hold
414
– – 0.01% 278
2022
Q4 		$30.9K Buy
+414
New +$31.9K 0.01% 281

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Compass Wealth Management's EW Position: Q3 2024 in Review

Compass Wealth Management sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 264 shares — an estimated $24.4K sold.

Compass Wealth Management first reported a position in EW in Q4 2022 and held it in 4 quarters. The position peaked at $34.3K in Q1 2023. 1,195 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Compass Wealth Management reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Compass Wealth Management sold 264 Edwards Lifesciences shares in Q3 2024, an estimated $24.4K.
  • Compass Wealth Management first reported a position in Edwards Lifesciences in Q4 2022 and held it in 4 quarters.
  • Compass Wealth Management's Edwards Lifesciences position peaked at $34.3K in Q1 2023.
  • 1,195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Compass Wealth Management's 13F filing for Q3 2024, filed 16 Oct 2024.